INS and type 2 diabetes mellitus: For MI as well as for the mortality outcomes, the risk reduction already at low consumption levels of 1–<2 servings/week was observed only among participants who had had type 2 diabetes less than 6 years, potentially indicating less severe/non-insulin treated disease.